A new study suggests nitrous oxide may offer a new treatment option for older adults with treatment-resistant depression.
A large meta-analysis suggests fecal microbiota transplantation may help reduce depressive symptoms, especially in patients ...
MedPage Today on MSN
Trial Questions Ketamine Use for Patients Hospitalized With Depression
A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group ...
News-Medical.Net on MSN
Genetic inflammatory signature defines depression subtypes and treatment response
Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond ...
Researchers from Trinity College, St Patrick’s Mental Health Services, Queen’s University Belfast, Ireland, investigate use ...
News-Medical.Net on MSN
Repeated ketamine infusions offer no extra benefit for people hospitalized with depression
Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have ...
Financially, Compass Pathways is well-capitalized with $221.9 million in cash, funding operations into 2027. Click here to ...
Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory ...
One man living with major depressive disorder shares how working with his psychiatrist led him to understand his treatment-emergent sexual dysfunction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback